It is also interesting that some of the compounds, when assessed for their effects on patient-derived ACC cells, were found to suppress the proliferation of these cells more strongly than the proliferation of control cells not expressing MYB-NFIB fusion proteins. This evidence concerns the gene NFIB and adrenal cortex carcinoma.